Heart Failure, Congestive Clinical Trial
Official title:
Collaborative Care for Heart Failure Patients With the Metabolic Syndrome
Heart failure is a condition where the heart does not pump enough blood to the rest of the
body. People with heart failure may have another condition called the "metabolic syndrome"(
having excess fat in the belly, high blood pressure, high fat in the blood, low level of good
cholesterol and high blood sugar). People who have both heart failure and the metabolic
syndrome often see many doctors. A new clinic has been formed at Ben Taub General Hospital
that includes a specialist in heart failure (cardiologist) and in the metabolic syndrome
(endocrinologist) as well as patient teaching. The goal of this study is to randomize
patients with the metabolic syndrome who are admitted to the hospital for heart failure to
this clinic (collaborative care) versus the usual doctor appointments (usual care). The
purpose of this study is to see if collaborative care is better medical care than usual care.
Specifically, we will see if patients in collaborative care will have:
1. fewer admissions to hospitals for illness
2. better blood pressure, sugar, fat and heart failure control
3. better patient satisfaction and knowledge about their diseases
4. lower levels of inflammation.
A striking feature of the Harris County Hospital District heart failure population is that
the prevalence of obesity (50.8%) and the metabolic syndrome (48.9%) exceeds that of the
general U.S. population. The metabolic syndrome is defined as the presence of 3 out of 5
components: abdominal obesity, elevated blood pressure, dyslipidemias (↑ triglycerides and ↓
high density lipoprotein) and insulin resistance and hyperglycemia. Current treatment
recommendations for the metabolic syndrome include lifestyle modification (diet, exercise,
and weight control) and targeted pharmaceutical therapy for the individual components.
Although specialized care for the metabolic syndrome has not been reported, separately, both
specialty heart failure care and endocrinology care have been shown to reduce hospital
admissions and health care costs, increase target medication titration and disease control,
improve quality of life, and survival in patients with heart failure and diabetes
respectively. As both heart failure and the metabolic syndrome are commonly found in the same
patients, collaborative out-patient management of both conditions in the same clinic is novel
and may have a significant impact on outcomes.
Hypothesis:
Compared to usual post-discharge follow-up, collaborative treatment of heart failure patients
with the metabolic syndrome by a team composed of an endocrinologist, cardiologist, patient
educator, nurse and case manager will result in:
- Decreased hospital readmissions and emergency room visits
- Health care cost savings
- Increased achievement of treatment goals (target blood pressure, HgbA1c, lipids, and
heart failure medication titration)
- Improved patient satisfaction, knowledge, and compliance
- Lower levels of markers of inflammation and insulin resistance
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01357850 -
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
|
Phase 2 | |
Recruiting |
NCT00532688 -
N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure
|
Phase 2/Phase 3 | |
Completed |
NCT00531661 -
CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients
|
N/A | |
Terminated |
NCT00383630 -
Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure
|
Phase 2 | |
Completed |
NCT00241761 -
Epidemiology of Depression and Heart Failure in Aging
|
N/A | |
Terminated |
NCT00125437 -
Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy
|
N/A | |
Completed |
NCT00149435 -
Cardiovascular Health Study (CHS) Events Follow-up Study
|
||
Completed |
NCT00159614 -
Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment
|
Phase 2 | |
Terminated |
NCT00357591 -
Randomized Trial for Patients With Chronic Heart Failure With Acute Decompensation
|
N/A | |
Completed |
NCT00094263 -
Long-Term Predictors of Morbidity in Older Age
|
N/A | |
Completed |
NCT00202579 -
Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure
|
Phase 2 | |
Completed |
NCT00048425 -
Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.
|
Phase 3 | |
Completed |
NCT00530426 -
Heart Failure Registry
|
Phase 4 | |
Completed |
NCT00023556 -
Genetic Architecture of Heart Disease in Rural Brazil
|
N/A | |
Terminated |
NCT00190359 -
Growth Hormone and Heart Failure
|
N/A | |
Completed |
NCT00004562 -
Occluded Artery Trial (OAT)
|
Phase 3 | |
Completed |
NCT00005265 -
Natural History of Coronary Heart Disease
|
N/A | |
Completed |
NCT02772068 -
Hemodynamic Response to Exercise in HFpEF Patients After Upregulation of SERCA2a
|
Early Phase 1 | |
Completed |
NCT02925546 -
A Phase I Study to Assess the Pharmacokinetics of GSK2798745 Tablets
|
Phase 1 | |
Completed |
NCT01074307 -
A Prospective, Open-labeled, Multi-centric Trial in Subjects With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in Korea
|
Phase 4 |